Federman & Sherwood Announces Filing of Securities Class Action Lawsuit Against Myriad Genetics, Inc.
April 23, 2018 16:56 ET
|
Federman & Sherwood
OKLAHOMA CITY, April 23, 2018 (GLOBE NEWSWIRE) -- Federman & Sherwood announces that on April 20, 2018, a class action lawsuit was filed in the United States District Court for the District of...
Myriad Pharmaceuticals, Inc. Established as an Independent Pharmaceutical Development Company
July 01, 2009 08:30 ET
|
Myrexis, Inc.
Company Will Advance Three Clinical Development Programs
in Oncology and Infectious Disease
Conference Call Scheduled for 10:00 AM EDT On July 1,...
Myriad Pharmaceuticals, Inc. to Host Initial Public Conference Call On July 1, 2009
June 29, 2009 10:05 ET
|
Myrexis, Inc.
SALT LAKE CITY, June 29, 2009 (GLOBE NEWSWIRE) -- Myriad Pharmaceuticals, Inc. (Nasdaq:MYRXV) today announced that it will hold a live webcast on Wednesday, July 1, 2009 at 10:00 AM EDT. Adrian...